Machine learning prediction of anemia events before and after talazoparib dose modification using TALAPRO-2 phase 3 trial data

19/11/2024
20/10/2026
EU PAS number:
EUPAS1000000344
Study
Ongoing
Documents
Study protocol
Initial protocol
English (639.72 KB - PDF) View document
Updated protocol
English (267.14 KB - PDF) View document
Study results
No information provided.
Study report
Study report
English (2.52 MB - PDF) View document
ENCePP Seal
No information provided.